Two St. Jude’s Defibrillators Approved
The FDA approved two new devices to treat individuals with heart failure and arrhythmias, the Current implantable cardioverter defibrillator (ICD) and Promote cardiac resynchronization therapy defibrillator (CRT-D).
These are the first devices from St. Jude’s to receive FDA approval based on a new hardware/software solution for implantable devices. The common base will facilitate upgrades.
Related stories:
- Defibrillator Analyzers Available
- Boston Scientific Lead Approved
- ICDs Improve Life Quality
- Defibrillator Industry Growth Slows Despite Large Untapped Market
May 17, 2007 Related topics: New Technology & Innovation, Cardiology